Strategic Move by Glenmark Pharmaceuticals Glenmark Pharmaceuticals Ltd. has announced its plan to divest its entire 7.84% stake in Glenmark Life Sciences Ltd. (GLS) through an offer for sale (OFS) in the secondary market. The board approved the sale of up to 96.09 lakh shares at a meeting on Wednesday. Additionally, Chairman and Managing Director …